Synovial tissue biomarker study to guide PVNS management
Official title: Synovial Tissue as a Biomarker in the Management of Pigmented Villonodular Synovitis
Run by Nantes University Hospital · NCT07503821 · Data updated 2026-11-12
Researchers will collect and analyze synovial tissue from adults with PVNS to see if tissue markers can help tailor treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Nantes University Hospital Academic / other |
| Locations | 3 sites (Lyon and 2 other locations) |
| Status | Recruiting |
| Started | October 30, 2026 |
| Main results expected | October 30, 2030 |
| Study ends | October 30, 2030 |
| Registry record updated | November 6, 2026 |
| Trial ID | NCT07503821 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with localized or diffuse PVNS who are referred for therapeutic management and are affiliated with a social security system.
✕Probably not a fit
Patients who do not have PVNS or who decline participation may not benefit from this biomarker-focused approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter, prospective study collects synovial tissue from adults with localized or diffuse PVNS undergoing therapy. The biopsies are used for diagnostic confirmation and research, including histology, immunohistochemistry, and high-throughput analyses. Participants are followed for one year with two visits (6 months and 12 months) to evaluate pain, function, and treatment response, then followed as per routine care for up to four years. The primary goal is to establish a patient biocollection and tissue quality suitable for biomarker discovery, with secondary aims assessing biopsy tolerance, patient acceptability, and the impact of treatments on synovial explants.
Why it matters
Potential benefit: If successful, this approach could enable personalized management of PVNS by using tissue biomarkers to guide therapy choices.
How similar studies have gone: Biomarker and tissue-based studies in PVNS and related synovial diseases have shown potential signals, but this approach remains exploratory in PVNS management.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient \>18 years * Diagnosis of localized or diffuse villonodular synovitis * Referred for therapeutic management * Affiliated with or benefiting from a social security scheme Exclusion Criteria: * Pregnant women * Nursing mothers * Protected patients: patients under guardianship or curatorship, safeguard of justice * Patients deprived of liberty * Curative anticoagulation * Thrombocytopenia \< 50,000 platelets/mm3
Where it's running
-
CHU de Nantes
Nantes, France Recruiting -
Hospices Civils de Lyon
Lyon, France Not yet recruiting -
Hôpital Cochin APHP
Paris, France Not yet recruiting
Study contacts
- Study coordinator: Benoit Le Goff, PU-PH
- Email: benoit.legoff@chu-nantes.fr
- Phone: 02 40 08 48 25
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Four-session focal shock wave therapy for vulvodynia in women
This study looks at whether four weekly sessions of low-intensity focal shock wave therapy help women with vulvodynia in real-life clinical practice.
-
Reproducibility of Digital Bite Mark Overlays in Adults
This study tests how consistently different people can create digital bite mark overlays from 3D dental scans in adults who need routine dental care.
-
Dental care for people living with HIV in Pays de la Loire
This study looks at whether people living with HIV in Pays de la Loire need any special dental management based on their health data.
-
68Ga-FAPI-46 PET imaging to stage ATTR-CM and spot progression
This study tests whether a gallium-68 labeled FAPI PET scan can help stage transthyretin cardiac amyloidosis and identify patients whose disease is progressing.
-
IL-1β blocker after pancreatic transplant to help prevent graft thrombosis
This trial tests whether adding Anakinra right after pancreatic transplant is safe for patients to see if it helps protect the new pancreas.
-
Home-based tDCS for depression: comparing treatment done at home vs in hospital
This study tests whether delivering transcranial direct current stimulation at home is as effective as in-hospital treatment for adults with moderate to severe depression.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.